組織学および細胞学の市場規模、シェア、動向分析レポート：検査タイプ別、製品別、用途別、地域別、セグメント予測、2025年～2030年

組織学および細胞学の市場成長と動向：

Grand View Research社の最新レポートによると、世界の組織学および細胞学の市場規模は2030年までに494億8,000万米ドルに達すると予測されています。

同市場は2025年から2030年にかけてCAGR 15.31％で成長すると予測されています。市場成長の要因としては、疾患の早期発見に対する需要の増加、病理検査室の標準化の進展、免疫組織化学の導入と顕微鏡検査の革新などが挙げられます。

各組織は、細胞病理学の世界の標準化のための共同研究に注力しており、市場成長にプラスの影響を与えています。例えば、2022年11月、トレーニングを通じてサハラ以南のアフリカにおけるがん登録を推進するため、ケニアに新規のIARC GICR協力センターが設立されました。この共同センターは、地域トレーニングコースとCanReg5ソフトウェアの実装と開発に重点を置いています。

さらに、各社は細胞診のための斬新で自動化された機器を発売しており、これが組織診・細胞診業界の成長にさらに寄与しています。例えば、2021年1月、F. Hoffmann-La Roche Ltdは、uPath HER2（4B5）画像解析とuPath HER2 Dual ISH画像解析の2つの自動デジタル病理アルゴリズムを発売しました。

COVID-19は、人工知能（AI）とデジタル化ソリューションの統合により、従来の病理ワークフローを変えるきっかけとなりました。パンデミックの間、これらのツールは病理学的症例の遠隔レビューを支援し、現在も支援し続けています。その結果、患者治療の遅れを防ぐことができます。COVID-19以降、デジタル病理学ソリューションの採用が増加していると企業は報告しています。

組織学および細胞学市場レポートハイライト

• 細胞診分野は2024年に最大の収益シェアを占め、細胞診システムの進歩に伴う計算分析ツールの統合により、予測期間中もこの傾向が続くと予測されます。
• 消耗品・試薬セグメントは組織学および細胞学業界を支配しており、これは消耗品市場で事業展開している企業のポートフォリオが拡大していることに起因しています。機器および分析ソフトウェアシステム分野は、自動組織検査機器に対する需要の急増に起因して、2025年から2030年にかけて大幅なCAGRで成長すると予想されています。
• 創薬・薬剤設計セグメントは、2024年に最も高い収益シェアを占め、予測期間中に最も速いCAGRで成長すると予測されています。
• 北米は、がんの蔓延、主要プレイヤーの存在、発達したヘルスケアインフラにより、2024年に最も高い収益を生み出す地域に浮上しました。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 組織学および細胞学市場の変数、動向、範囲

• 市場系統の見通し
  • 親市場の見通し
  • 関連/付随市場の見通し
• 市場力学
  • 市場促進要因分析
  • 市場抑制要因分析
• 組織学および細胞学市場分析ツール
  • 業界分析- ポーターのファイブフォース分析
  • PESTEL分析
  • 価格分析

第4章 組織学および細胞学市場：検査タイプの推定・動向分析

• 世界の組織学および細胞学市場：ダッシュボード
• 世界の組織学および細胞学市場：変動分析
• 世界の組織学および細胞学市場：収益
• 組織学
  • 技法別
• 細胞学
  • 技法別
  • 用途別

第5章 組織学および細胞学市場：製品推定・動向分析

• 世界の組織学および細胞学市場：製品ダッシュボード
• 世界の組織学および細胞学市場：製品変動分析
• 世界の組織学および細胞学市場：製品別収益
  • 機器および分析ソフトウェアシステム
  • 消耗品と試薬

第6章 組織学および細胞学市場：用途の推定・動向分析

• 世界の組織学および細胞学市場：用途ダッシュボード
• 世界の組織学および細胞学市場：用途変動分析
• 世界の組織学および細胞学市場：用途別収益
• 創薬と設計
• 臨床診断
  • ポイントオブケア（PoC）
  • 非PoC
• 研究

第7章 組織学および細胞学市場：検査の種類、製品、用途、および調査手法別地域推定・動向分析

• 地域ダッシュボード
• 市場規模、予測動向分析、2018年から2030年まで：
• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • 英国
  • ドイツ
  • フランス
  • イタリア
  • スペイン
  • ノルウェー
  • スウェーデン
  • デンマーク
• アジア太平洋
  • 日本
  • 中国
  • インド
  • オーストラリア
  • 韓国
  • タイ
• ラテンアメリカ
  • ブラジル
  • アルゼンチン
• 中東・アフリカ
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • クウェート

第8章 競合情勢

• 主要市場参入企業による最近の動向と影響分析
• 企業/競合の分類
• ベンダー情勢
  • 主要販売代理店およびチャネルパートナーのリスト
  • Key customers
  • Key company market share analysis, 2024
  • Hologic, Inc.
  • Abbott
  • Becton, Dickinson and Company
  • F. Hoffmann-La Roche Ltd
  • Merck KGaA
  • Thermo Fisher Scientific, Inc.
  • Danaher
  • Sysmex Corporation
  • Trivitron Healthcare
  • Koninklijke Philips NV

List of Tables

• Table 1 List of abbreviation
• Table 2 North America Histology and cytology market, by region, 2018 - 2030 (USD Million)
• Table 3 North America Histology and cytology market, by type of examination, 2018 - 2030 (USD Million)
• Table 4 North America Histology and cytology market, by product, 2018 - 2030 (USD Million)
• Table 5 North America Histology and cytology market, by application, 2018 - 2030 (USD Million)
• Table 6 U.S. Histology and cytology market, by type of examination, 2018 - 2030 (USD Million)
• Table 7 U.S. Histology and cytology market, by application, 2018 - 2030 (USD Million)
• Table 8 U.S. Histology and cytology market, by product, 2018 - 2030 (USD Million)
• Table 9 Canada Histology and cytology market, by type of examination, 2018 - 2030 (USD Million)
• Table 10 Canada Histology and cytology market, by application, 2018 - 2030 (USD Million)
• Table 11 Canada Histology and cytology market, by product, 2018 - 2030 (USD Million)
• Table 12 Mexico Histology and cytology market, by type of examination, 2018 - 2030 (USD Million)
• Table 13 Mexico Histology and cytology market, by application, 2018 - 2030 (USD Million)
• Table 14 Mexico Histology and cytology market, by product, 2018 - 2030 (USD Million)
• Table 15 Europe Histology and cytology market, by region, 2018 - 2030 (USD Million)
• Table 16 Europe Histology and cytology market, by type of examination, 2018 - 2030 (USD Million)
• Table 17 Europe Histology and cytology market, by application, 2018 - 2030 (USD Million)
• Table 18 Europe Histology and cytology market, by product, 2018 - 2030 (USD Million)
• Table 19 Germany Histology and cytology market, by type of examination, 2018 - 2030 (USD Million)
• Table 20 Germany Histology and cytology market, by application, 2018 - 2030 (USD Million)
• Table 21 Germany Histology and cytology market, by product, 2018 - 2030 (USD Million)
• Table 22 UK Histology and cytology market, by type of examination, 2018 - 2030 (USD Million)
• Table 23 UK Histology and cytology market, by application, 2018 - 2030 (USD Million)
• Table 24 UK Histology and cytology market, by product, 2018 - 2030 (USD Million)
• Table 25 France Histology and cytology market, by type of examination, 2018 - 2030 (USD Million)
• Table 26 France Histology and cytology market, by application, 2018 - 2030 (USD Million)
• Table 27 France Histology and cytology market, by product, 2018 - 2030 (USD Million)
• Table 28 Italy Histology and cytology market, by type of examination, 2018 - 2030 (USD Million)
• Table 29 Italy Histology and cytology market, by application, 2018 - 2030 (USD Million)
• Table 30 Italy Histology and cytology market, by product, 2018 - 2030 (USD Million)
• Table 31 Spain Histology and cytology market, by type of examination, 2018 - 2030 (USD Million)
• Table 32 Spain Histology and cytology market, by application, 2018 - 2030 (USD Million)
• Table 33 Spain Histology and cytology market, by product, 2018 - 2030 (USD Million)
• Table 34 Denmark Histology and cytology market, by type of examination, 2018 - 2030 (USD Million)
• Table 35 Denmark Histology and cytology market, by application, 2018 - 2030 (USD Million)
• Table 36 Denmark Histology and cytology market, by product, 2018 - 2030 (USD Million)
• Table 37 Sweden Histology and cytology market, by type of examination, 2018 - 2030 (USD Million)
• Table 38 Sweden Histology and cytology market, by application, 2018 - 2030 (USD Million)
• Table 39 Sweden Histology and cytology market, by product, 2018 - 2030 (USD Million)
• Table 40 Norway Histology and cytology market, by type of examination, 2018 - 2030 (USD Million)
• Table 41 Norway Histology and cytology market, by application, 2018 - 2030 (USD Million)
• Table 42 Norway Histology and cytology market, by product, 2018 - 2030 (USD Million)
• Table 43 Asia Pacific Histology and cytology market, by region, 2018 - 2030 (USD Million)
• Table 44 Asia Pacific Histology and cytology market, by type of examination, 2018 - 2030 (USD Million)
• Table 45 Asia Pacific Histology and cytology market, by application, 2018 - 2030 (USD Million)
• Table 46 Asia Pacific Histology and cytology market, by product, 2018 - 2030 (USD Million)
• Table 47 China Histology and cytology market, by type of examination, 2018 - 2030 (USD Million)
• Table 48 China Histology and cytology market, by application, 2018 - 2030 (USD Million)
• Table 49 China Histology and cytology market, by product, 2018 - 2030 (USD Million)
• Table 50 Japan Histology and cytology market, by type of examination, 2018 - 2030 (USD Million)
• Table 51 Japan Histology and cytology market, by application, 2018 - 2030 (USD Million)
• Table 52 Japan Histology and cytology market, by product, 2018 - 2030 (USD Million)
• Table 53 India Histology and cytology market, by type of examination, 2018 - 2030 (USD Million)
• Table 54 India Histology and cytology market, by application, 2018 - 2030 (USD Million)
• Table 55 India Histology and cytology market, by product, 2018 - 2030 (USD Million)
• Table 56 South Korea Histology and cytology market, by type of examination, 2018 - 2030 (USD Million)
• Table 57 South Korea Histology and cytology market, by application, 2018 - 2030 (USD Million)
• Table 58 South Korea Histology and cytology market, by product, 2018 - 2030 (USD Million)
• Table 59 Australia Histology and cytology market, by type of examination, 2018 - 2030 (USD Million)
• Table 60 Australia Histology and cytology market, by application, 2018 - 2030 (USD Million)
• Table 61 Australia Histology and cytology market, by product, 2018 - 2030 (USD Million)
• Table 62 Thailand Histology and cytology market, by type of examination, 2018 - 2030 (USD Million)
• Table 63 Thailand Histology and cytology market, by application, 2018 - 2030 (USD Million)
• Table 64 Thailand Histology and cytology market, by product, 2018 - 2030 (USD Million)
• Table 65 Latin America Histology and cytology market, by region, 2018 - 2030 (USD Million)
• Table 66 Latin America Histology and cytology market, by type of examination, 2018 - 2030 (USD Million)
• Table 67 Latin America Histology and cytology market, by application, 2018 - 2030 (USD Million)
• Table 68 Latin America Histology and cytology market, by product, 2018 - 2030 (USD Million)
• Table 69 Brazil Histology and cytology market, by type of examination, 2018 - 2030 (USD Million)
• Table 70 Brazil Histology and cytology market, by application, 2018 - 2030 (USD Million)
• Table 71 Brazil Histology and cytology market, by product, 2018 - 2030 (USD Million)
• Table 72 Argentina Histology and cytology market, by type of examination, 2018 - 2030 (USD Million)
• Table 73 Argentina Histology and cytology market, by application, 2018 - 2030 (USD Million)
• Table 74 Argentina Histology and cytology market, by product, 2018 - 2030 (USD Million)
• Table 75 MEA Histology and cytology market, by region, 2018 - 2030 (USD Million)
• Table 76 MEA Histology and cytology market, by type of examination, 2018 - 2030 (USD Million)
• Table 77 MEA Histology and cytology market, by application, 2018 - 2030 (USD Million)
• Table 78 MEA Histology and cytology market, by product, 2018 - 2030 (USD Million)
• Table 79 South Africa Histology and cytology market, by type of examination, 2018 - 2030 (USD Million)
• Table 80 South Africa Histology and cytology market, by application, 2018 - 2030 (USD Million)
• Table 81 South Africa Histology and cytology market, by product, 2018 - 2030 (USD Million)
• Table 82 Saudi Arabia Histology and cytology market, by type of examination, 2018 - 2030 (USD Million)
• Table 83 Saudi Arabia Histology and cytology market, by application, 2018 - 2030 (USD Million)
• Table 84 Saudi Arabia Histology and cytology market, by product, 2018 - 2030 (USD Million)
• Table 85 UAE Histology and cytology market, by type of examination, 2018 - 2030 (USD Million)
• Table 86 UAE Histology and cytology market, by application, 2018 - 2030 (USD Million)
• Table 87 UAE Histology and cytology market, by product, 2018 - 2030 (USD Million)
• Table 88 Kuwait Histology and cytology market, by type of examination, 2018 - 2030 (USD Million)
• Table 89 Kuwait Histology and cytology market, by application, 2018 - 2030 (USD Million)
• Table 90 Kuwait Histology and cytology market, by product, 2018 - 2030 (USD Million)

List of Figures

• Fig. 1 Market research process
• Fig. 2 Data triangulation techniques
• Fig. 3 Primary research pattern
• Fig. 4 Primary interviews in North America
• Fig. 5 Primary interviews in Europe
• Fig. 6 Primary interviews in APAC
• Fig. 7 Primary interviews in Latin America
• Fig. 8 Primary interviews in MEA
• Fig. 9 Market research approaches
• Fig. 10 Value-chain-based sizing & forecasting
• Fig. 11 QFD modeling for market share assessment
• Fig. 12 Market formulation & validation
• Fig. 13 Histology and cytology market: market outlook
• Fig. 14 Histology and cytology competitive insights
• Fig. 15 Parent market outlook
• Fig. 16 Related/ancillary market outlook
• Fig. 17 Histology and cytology market driver impact
• Fig. 18 Histology and cytology market restraint impact
• Fig. 19 Histology and cytology market: Type of examination movement analysis
• Fig. 20 Histology and cytology market: Type of examination outlook and key takeaways
• Fig. 21 Histology market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 22 Microscopy market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 23 Immunohistochemistry market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 24 Molecular pathology market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 25 Cryostat & microtomy market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 26 Cytology market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 27 Microscopy estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 28 Immunohistochemistry market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 29 Molecular pathology market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 30 Cryostat & microtomy market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 31 Cervical Cancer market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 32 Breast Cancer market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 33 Bladder Cancer market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 34 Lung Cancer market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 35 Other Cancers market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 36 Histology and cytology market: Product movement analysis
• Fig. 37 Histology and cytology market: Product outlook and key takeaways
• Fig. 38 Instruments and analysis software system market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 39 Consumable and reagents market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 40 Histology and cytology market: Application movement analysis
• Fig. 41 Histology and cytology market: Application outlook and key takeaways
• Fig. 42 Drug discovery & designing market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 43 Clinical diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 44 Point-of-Care (PoC) market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 45 Non-PoC market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 46 Research market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 47 Global Histology and Cytology market: Regional movement analysis
• Fig. 48 Global Histology and Cytology market: Regional outlook and key takeaways
• Fig. 49 Global Histology and Cytology market share and leading players
• Fig. 50 North America, by country
• Fig. 51 North America market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 52 U.S. key country dynamics
• Fig. 53 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 54 Canada key country dynamics
• Fig. 55 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 56 Mexico key country dynamics
• Fig. 57 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 58 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 59 UK key country dynamics
• Fig. 60 UK market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 61 Germany key country dynamics
• Fig. 62 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 63 France key country dynamics
• Fig. 64 France market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 65 Italy key country dynamics
• Fig. 66 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 67 Spain key country dynamics
• Fig. 68 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 69 Denmark key country dynamics
• Fig. 70 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 71 Sweden key country dynamics
• Fig. 72 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 73 Norway key country dynamics
• Fig. 74 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 75 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 76 China key country dynamics
• Fig. 77 China market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 78 Japan key country dynamics
• Fig. 79 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 80 India key country dynamics
• Fig. 81 India market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 82 Thailand key country dynamics
• Fig. 83 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 84 South Korea key country dynamics
• Fig. 85 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 86 Australia key country dynamics
• Fig. 87 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 88 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 89 Brazil key country dynamics
• Fig. 90 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 91 Argentina key country dynamics
• Fig. 92 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 93 Middle East and Africa market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 94 South Africa key country dynamics
• Fig. 95 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 96 Saudi Arabia key country dynamics
• Fig. 97 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 98 UAE key country dynamics
• Fig. 99 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 100 Kuwait key country dynamics
• Fig. 101 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 102 Market share of key market players- Histology and cytology market

Histology And Cytology Market Growth & Trends:

The global histology and cytology market size is anticipated to reach USD 49.48 billion by 2030, according to a new report by Grand View Research, Inc. The market is projected to grow at a CAGR of 15.31% from 2025 to 2030. The factors contributing to market growth include increasing demand for early detection of diseases, increased standardization of pathology laboratories, and implementation of immunohistochemistry and innovation in microscopy.

Organizations are focusing on collaborations for the standardization of cytopathology globally, positively impacting market growth. For instance, in November 2022, a novel IARC GICR collaboration center was established in Kenya to advance cancer registration in sub-Saharan Africa via training. The collaborating center focuses on regional training courses and the implementation & development of the CanReg5 software.

Moreover, companies are launching novel and automated instruments for cytology which can be further attributed to the histology and cytology industry growth. For instance, in January 2021, F. Hoffmann-La Roche Ltd launched uPath HER2 (4B5) image analysis and uPath HER2 Dual ISH image analysis-two automated digital pathology algorithms that offer rapid & accurate patient diagnoses in breast cancer.

COVID-19 became a catalyst for changing traditional pathology workflows with the integration of artificial intelligence (AI) and digitalization solutions. During the pandemic, these tools helped and continue to assist in the remote reviewing of pathological cases. Thus, preventing delays in patient care. Companies have reported increasing adoption of digital pathology solutions post-COVID-19.

Histology And Cytology Market Report Highlights:

• The cytology segment accounted for the largest revenue share in 2024 and is expected to continue the trend in the forecast period owing to the integration of computational analytical tools for advancing cytology systems
• The consumables and reagents segment dominated the histology and cytology industry, attributed to the expanding portfolios of the entities operating in the consumable market. The instruments and analysis software system segment is expected to grow at a substantial CAGR from 2025 to 2030, attributed to the steep increase in the demand for automated histology instruments
• Drug discovery & designing segment accounted for the highest revenue share in 2024 and is anticipated to grow at the fastest CAGR over the forecast period, owing to the growing importance of cytopathology in disease understanding, further aimed at rapid drug development
• North America emerged as the highest revenue-generating region in 2024, owing to the prevalence of cancer, the presence of key players, and the developed healthcare infrastructure

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Type of Examination
  • 1.2.2. Product
  • 1.2.3. Application
  • 1.2.4. Regional scope
  • 1.2.5. Estimates and forecasts timeline
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased database
  • 1.4.2. GVR's internal database
  • 1.4.3. Secondary sources
  • 1.4.4. Primary research
  • 1.4.5. Details of primary research
    • 1.4.5.1. Data for primary interviews in North America
    • 1.4.5.2. Data for primary interviews in Europe
    • 1.4.5.3. Data for primary interviews in Asia Pacific
    • 1.4.5.4. Data for primary interviews in Latin America
    • 1.4.5.5. Data for Primary interviews in MEA
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis (Model 1)
  • 1.7.2. Approach 1: Commodity flow approach
  • 1.7.3. Volume price analysis (Model 2)
  • 1.7.4. Approach 2: Volume price analysis
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Type of examination outlook
  • 2.2.2. Product outlook
  • 2.2.3. Application outlook
  • 2.2.4. Regional outlook
• 2.3. Competitive Insights

Chapter 3. Histology and Cytology Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
    • 3.2.1.1. Rising incidence of cancer
    • 3.2.1.2. Technological developments
    • 3.2.1.3. Increase in awareness programs for cervical cancer screening
  • 3.2.2. Market restraint analysis
    • 3.2.2.1. Low sensitivity of cytology tests
    • 3.2.2.2. Conditions required for specimens and problem of mislabeled specimens
• 3.3. Histology and cytology Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Supplier power
    • 3.3.1.2. Buyer power
    • 3.3.1.3. Substitution threat
    • 3.3.1.4. Threat of new entrant
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Technological landscape
    • 3.3.2.3. Economic landscape
  • 3.3.3. Pricing Analysis

Chapter 4. Histology and cytology Market: Type of Examination Estimates & Trend Analysis

• 4.1. Global Histology and Cytology Market: Type Of Examination Dashboard
• 4.2. Global Histology and Cytology Market: Type of Examination Movement Analysis
• 4.3. Global Histology and Cytology Market by Type of Examination, Revenue
• 4.4. Histology
  • 4.4.1. Histology market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.4.2. By Technique
    • 4.4.2.1. Microscopy
      • 4.4.2.1.1. Microscopy market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.2.2. Immunohistochemistry
      • 4.4.2.2.1. Immunohistochemistry market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.2.3. Molecular pathology
      • 4.4.2.3.1. Molecular pathology market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.2.4. Cryostat & Microtomy
      • 4.4.2.4.1. Cryostat & Microtomy market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.4.3. Cytology
    • 4.4.3.1. Cytology market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.4.4. By Technique
    • 4.4.4.1. Microscopy
      • 4.4.4.1.1. Microscopy market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.4.2. Immunohistochemistry
      • 4.4.4.2.1. Immunohistochemistry market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.4.3. Molecular pathology
      • 4.4.4.3.1. Molecular pathology market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.4.4. Cryostat & Microtomy
      • 4.4.4.4.1. Cryostat & Microtomy market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.4.5. By Application
    • 4.4.5.1. Breast Cancer
      • 4.4.5.1.1. Breast Cancer market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.5.2. Cervical Cancer
      • 4.4.5.2.1. Cervical Cancer market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.5.3. Bladder Cancer
      • 4.4.5.3.1. Bladder Cancer market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.5.4. Lung Cancer
      • 4.4.5.4.1. Lung Cancer market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.5.5. Other Cancers
      • 4.4.5.5.1. Other Cancer market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Histology and cytology Market: Product Estimates & Trend Analysis

• 5.1. Global Histology and Cytology Market: Product Dashboard
• 5.2. Global Histology and Cytology Market: Product Movement Analysis
• 5.3. Global Histology and Cytology Market by Product, Revenue
  • 5.3.1. Instruments and Analysis Software System
  • 5.3.2. Instruments and analysis software system market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.3.3. Consumable and Reagents
  • 5.3.4. Consumable and reagents market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Histology and cytology Market: Application Estimates & Trend Analysis

• 6.1. Global Histology and Cytology Market: Application Dashboard
• 6.2. Global Histology and Cytology Market: Application Movement Analysis
• 6.3. Global Histology and Cytology Market by Application, Revenue
• 6.4. Drug Discovery & Designing
  • 6.4.1. Drug discovery & designing market estimates and forecasts 2018 to 2030 (USD Million)
• 6.5. Clinical Diagnostics
  • 6.5.1. Clinical diagnostics market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.5.2. Point-of-Care (PoC)
    • 6.5.2.1. Point-of-Care (PoC) market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.5.3. Non-PoC
    • 6.5.3.1. Non-PoC market estimates and forecasts 2018 to 2030 (USD Million)
• 6.6. Research
  • 6.6.1. Research market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Histology and cytology Market: Regional Estimates & Trend Analysis by Type of Examination, Product, Application and Methodology

• 7.1. Regional Dashboard
• 7.2. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
• 7.3. North America
  • 7.3.1. U.S.
    • 7.3.1.1. Key country dynamics
    • 7.3.1.2. Regulatory framework/ reimbursement structure
    • 7.3.1.3. Competitive scenario
    • 7.3.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.3.2. Canada
    • 7.3.2.1. Key country dynamics
    • 7.3.2.2. Regulatory framework/ reimbursement structure
    • 7.3.2.3. Competitive scenario
    • 7.3.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.3.3. Mexico
    • 7.3.3.1. Key country dynamics
    • 7.3.3.2. Regulatory framework/ reimbursement structure
    • 7.3.3.3. Competitive scenario
    • 7.3.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
• 7.4. Europe
  • 7.4.1. UK
    • 7.4.1.1. Key country dynamics
    • 7.4.1.2. Regulatory framework/ reimbursement structure
    • 7.4.1.3. Competitive scenario
    • 7.4.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4.2. Germany
    • 7.4.2.1. Key country dynamics
    • 7.4.2.2. Regulatory framework/ reimbursement structure
    • 7.4.2.3. Competitive scenario
    • 7.4.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4.3. France
    • 7.4.3.1. Key country dynamics
    • 7.4.3.2. Regulatory framework/ reimbursement structure
    • 7.4.3.3. Competitive scenario
    • 7.4.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4.4. Italy
    • 7.4.4.1. Key country dynamics
    • 7.4.4.2. Regulatory framework/ reimbursement structure
    • 7.4.4.3. Competitive scenario
    • 7.4.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4.5. Spain
    • 7.4.5.1. Key country dynamics
    • 7.4.5.2. Regulatory framework/ reimbursement structure
    • 7.4.5.3. Competitive scenario
    • 7.4.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4.6. Norway
    • 7.4.6.1. Key country dynamics
    • 7.4.6.2. Regulatory framework/ reimbursement structure
    • 7.4.6.3. Competitive scenario
    • 7.4.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4.7. Sweden
    • 7.4.7.1. Key country dynamics
    • 7.4.7.2. Regulatory framework/ reimbursement structure
    • 7.4.7.3. Competitive scenario
    • 7.4.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4.8. Denmark
    • 7.4.8.1. Key country dynamics
    • 7.4.8.2. Regulatory framework/ reimbursement structure
    • 7.4.8.3. Competitive scenario
    • 7.4.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
• 7.5. Asia Pacific
  • 7.5.1. Japan
    • 7.5.1.1. Key country dynamics
    • 7.5.1.2. Regulatory framework/ reimbursement structure
    • 7.5.1.3. Competitive scenario
    • 7.5.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5.2. China
    • 7.5.2.1. Key country dynamics
    • 7.5.2.2. Regulatory framework/ reimbursement structure
    • 7.5.2.3. Competitive scenario
    • 7.5.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5.3. India
    • 7.5.3.1. Key country dynamics
    • 7.5.3.2. Regulatory framework/ reimbursement structure
    • 7.5.3.3. Competitive scenario
    • 7.5.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5.4. Australia
    • 7.5.4.1. Key country dynamics
    • 7.5.4.2. Regulatory framework/ reimbursement structure
    • 7.5.4.3. Competitive scenario
    • 7.5.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5.5. South Korea
    • 7.5.5.1. Key country dynamics
    • 7.5.5.2. Regulatory framework/ reimbursement structure
    • 7.5.5.3. Competitive scenario
    • 7.5.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5.6. Thailand
    • 7.5.6.1. Key country dynamics
    • 7.5.6.2. Regulatory framework/ reimbursement structure
    • 7.5.6.3. Competitive scenario
    • 7.5.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
• 7.6. Latin America
  • 7.6.1. Brazil
    • 7.6.1.1. Key country dynamics
    • 7.6.1.2. Regulatory framework/ reimbursement structure
    • 7.6.1.3. Competitive scenario
    • 7.6.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6.2. Argentina
    • 7.6.2.1. Key country dynamics
    • 7.6.2.2. Regulatory framework/ reimbursement structure
    • 7.6.2.3. Competitive scenario
    • 7.6.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
• 7.7. MEA
  • 7.7.1. South Africa
    • 7.7.1.1. Key country dynamics
    • 7.7.1.2. Regulatory framework/ reimbursement structure
    • 7.7.1.3. Competitive scenario
    • 7.7.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7.2. Saudi Arabia
    • 7.7.2.1. Key country dynamics
    • 7.7.2.2. Regulatory framework/ reimbursement structure
    • 7.7.2.3. Competitive scenario
    • 7.7.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7.3. UAE
    • 7.7.3.1. Key country dynamics
    • 7.7.3.2. Regulatory framework/ reimbursement structure
    • 7.7.3.3. Competitive scenario
    • 7.7.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7.4. Kuwait
    • 7.7.4.1. Key country dynamics
    • 7.7.4.2. Regulatory framework/ reimbursement structure
    • 7.7.4.3. Competitive scenario
    • 7.7.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Recent Developments & Impact Analysis, By Key Market Participants
• 8.2. Company/Competition Categorization
• 8.3. Vendor Landscape
  • 8.3.1. List of key distributors and channel partners
  • 8.3.2. Key customers
  • 8.3.3. Key company market share analysis, 2024
  • 8.3.4. Hologic, Inc.
    • 8.3.4.1. Company overview
    • 8.3.4.2. Financial performance
    • 8.3.4.3. Product benchmarking
    • 8.3.4.4. Strategic initiatives
  • 8.3.5. Abbott
    • 8.3.5.1. Company overview
    • 8.3.5.2. Financial performance
    • 8.3.5.3. Product benchmarking
    • 8.3.5.4. Strategic initiatives
  • 8.3.6. Becton, Dickinson and Company
    • 8.3.6.1. Company overview
    • 8.3.6.2. Financial performance
    • 8.3.6.3. Product benchmarking
    • 8.3.6.4. Strategic initiatives
  • 8.3.7. F. Hoffmann-La Roche Ltd
    • 8.3.7.1. Company overview
    • 8.3.7.2. Financial performance
    • 8.3.7.3. Product benchmarking
    • 8.3.7.4. Strategic initiatives
  • 8.3.8. Merck KGaA
    • 8.3.8.1. Company overview
    • 8.3.8.2. Financial performance
    • 8.3.8.3. Product benchmarking
    • 8.3.8.4. Strategic initiatives
  • 8.3.9. Thermo Fisher Scientific, Inc.
    • 8.3.9.1. Company overview
    • 8.3.9.2. Financial performance
    • 8.3.9.3. Product benchmarking
    • 8.3.9.4. Strategic initiatives
  • 8.3.10. Danaher
    • 8.3.10.1. Company overview
    • 8.3.10.2. Financial performance
    • 8.3.10.3. Product benchmarking
    • 8.3.10.4. Strategic initiatives
  • 8.3.11. Sysmex Corporation
    • 8.3.11.1. Company overview
    • 8.3.11.2. Financial performance
    • 8.3.11.3. Product benchmarking
    • 8.3.11.4. Strategic initiatives
  • 8.3.12. Trivitron Healthcare
    • 8.3.12.1. Company overview
    • 8.3.12.2. Financial performance
    • 8.3.12.3. Product benchmarking
    • 8.3.12.4. Strategic initiatives
  • 8.3.13. Koninklijke Philips N.V.
    • 8.3.13.1. Company overview
    • 8.3.13.2. Financial performance
    • 8.3.13.3. Product benchmarking
    • 8.3.13.4. Strategic initiatives